Cost Comparison
Thymosin Alpha-1 pricing through legitimate compounding pharmacies ranges from $150-300 per month for standard dosing protocols, with costs varying based on pharmacy location and prescription volume[55]. Patients requiring higher doses for cancer treatment may
This comparison does not assign a generated winner or score.
- Thymosin Alpha-1 pricing through legitimate compounding pharmacies ranges from $150-300 per month for standard dosing protocols, with costs varying based on pharmacy location and prescription volume[55]. Patients requiring higher doses for cancer treatment may face monthly costs of $400-600 through compounded sources[56]. Insurance coverage remains limited, as most plans classify Thymosin Alpha-1 as investigational for most indications[57]. Some specialty pharmacies offer patient assistance programs providing 20-30% discounts for cash-paying patients[58]. International sources may offer lower pricing, but quality and purity cannot be verified without proper analytical testing[59].
- TB-500 pricing operates entirely in gray market channels, with significant variability in cost and quality[60]. Research chemical suppliers typically charge $200-500 per month for standard dosing protocols, with prices fluctuating based on supply chain factors[61]. The lack of regulatory oversight means purity and potency vary dramatically between suppliers, with some products containing less than 50% of labeled TB-500 content[62]. Higher-priced suppliers claiming pharmaceutical-grade quality may charge $600-800 monthly, though these claims cannot be independently verified[63]. The legal risks associated with TB-500 acquisition add additional costs and complications for potential users[64].
- Monthly cost (standard dose)
- $150-300
- $200-500
- High-dose protocols
- $400-600
- $600-800
- Insurance coverage
- Limited/none
- None
- Patient assistance
- 20-30% discounts available
- Quality assurance
- Compounding pharmacy standards
- Unregulated
- Legal acquisition
- Prescription required
- Prohibited